CML Treatment - Investigational Agents, Reducing Dosage to Reduce Side-effects & Discontinuation Studies
By
Indy Hematology Review
FEATURING
Richard Larson
By
Indy Hematology Review
FEATURING
Richard Larson
Login to view comments.
Click here to Login